Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Neurocrine’s New CAH Drug, Krenicity, Gets FDA Approval—Here’s What You Need to Know

Daniel Kim Views  

Neurocrine Biosciences\' treatment for the rare genetic disorder CAH has received FDA approval in the United States
Medical Today DB

In a significant advancement for rare disease treatment, the U.S. Food and Drug Administration (FDA) has approved Neurocrine Biosciences’ new therapy for congenital adrenal hyperplasia (CAH).

The FDA recently approved Krenicity, a novel therapy by Neurocrine Biosciences designed specifically for typical CAH. This approval represents a pivotal milestone in the management of this rare condition.

CAH is a rare inherited disorder that affects the adrenal glands. These glands produce essential hormones such as cortisol and androgens. Patients with CAH often fail to produce sufficient cortisol, which is critical for stress regulation, while overproducing androgen hormones similar to testosterone.

To compensate for these hormonal imbalances, CAH patients typically rely on higher-than-normal doses of glucocorticoids to supplement cortisol deficiency and suppress excessive androgen production.

The FDA has approved Krenicity for adults and children aged 4 and older with CAH to be used alongside standard glucocorticoid therapy. A Neurocrine spokesperson stated that Krenicity will become commercially available within a week.

Krenicity’s mechanism of action involves reducing the overproduction of androgens, which in turn allows for lower glucocorticoid dosage requirements.

Neurocrine’s clinical trials showed promising results. In a 24-week study involving 122 adult CAH patients, those treated with Krenicity twice daily successfully reduced their daily glucocorticoid dose by up to 27% while maintaining stable levels of androstenedione, a key androgen hormone. These outcomes contrasted with those of the 60 patients who received a placebo.

The drug demonstrated similar efficacy in pediatric patients. In a 28-week trial involving 69 children with CAH, participants treated with Krenicity twice daily maintained stable hormone levels despite reducing their daily glucocorticoid dose by 18%, compared to the placebo group.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LIFESTYLE] Latest Stories

  • Why Hong Kong’s WinterFest Should Be Your Next Holiday Getaway
  • Avoid These Christmas Health Pitfalls to Keep Your Festivities Fun and Safe
  • Meet the Oldest Ever Miss France Winner: Angélique Angarni-Filopon Makes History
  • 25 Years of Poor Sleep? Here’s What It Really Does to Your Looks
  • Fight Hypertension Naturally: 5 Delicious Foods for Lower Blood Pressure
  • Why Greek Yogurt is the Weight-Loss Wonder You’ve Been Waiting For

You May Also Like

  • 1
    California Car Crash Lands Right in a Swimming Pool – Driver Escapes with Minor Injuries

    DEBATE 

  • 2
    Did TikTok Help Russia Interfere in Romania’s Election? EU Is About to Find Out

    WORLD 

  • 3
    China's Temu Tops U.S. App Store Again, Beats Instagram, TikTok in 2024

    BUSINESS 

  • 4
    Shocking Footage Shows North Korean Troops in Combat—50 Killed in 3 Days

    LATEST 

  • 5
    Injured North Korean Troops Filmed in Russian Hospital After Deadly Ukrainian Drone Strike

    DEBATE 

Popular Now

  • 1
    Is Dinga Dinga the Next Epidemic? Uganda’s Mysterious Illness Causes Fear and Confusion

    WORLD 

  • 2
    Poll Shocker: 71.5% of South Koreans Support President Yoon’s Arrest Over Insurrection

    ASIA 

  • 3
    North Korean Smuggler Busted in Russia With 12 Bear Paws Hidden in His Luggage

    DEBATE 

  • 4
    South Korea Gears Up for Intense Air Defense Drill Amid Rising Tensions with North Korea

    LATEST 

  • 5
    Why Are North Korean Soldiers Dying in Ukraine? The Deadly Frontline Battle Revealed

    WORLD 

Must-Reads

  • 1
    California Car Crash Lands Right in a Swimming Pool – Driver Escapes with Minor Injuries

    DEBATE 

  • 2
    Did TikTok Help Russia Interfere in Romania’s Election? EU Is About to Find Out

    WORLD 

  • 3
    China's Temu Tops U.S. App Store Again, Beats Instagram, TikTok in 2024

    BUSINESS 

  • 4
    Shocking Footage Shows North Korean Troops in Combat—50 Killed in 3 Days

    LATEST 

  • 5
    Injured North Korean Troops Filmed in Russian Hospital After Deadly Ukrainian Drone Strike

    DEBATE 

Popular Now

  • 1
    Is Dinga Dinga the Next Epidemic? Uganda’s Mysterious Illness Causes Fear and Confusion

    WORLD 

  • 2
    Poll Shocker: 71.5% of South Koreans Support President Yoon’s Arrest Over Insurrection

    ASIA 

  • 3
    North Korean Smuggler Busted in Russia With 12 Bear Paws Hidden in His Luggage

    DEBATE 

  • 4
    South Korea Gears Up for Intense Air Defense Drill Amid Rising Tensions with North Korea

    LATEST 

  • 5
    Why Are North Korean Soldiers Dying in Ukraine? The Deadly Frontline Battle Revealed

    WORLD 

Share it on...